New news MXC

Our Interim GMP Certification

We are very excited to announce that MGC Pharma has been formally granted an interim Good Manufacturing Practice (GMP) certification.
This comes after 18 months of formal inspections, reports and construction at our European Manufacturing facility.
This milestone achievement is one of the final steps in formally acquiring a full GMP license. A GMP license will give MGC the proper approval needed to produce and distribute the first batch of our groundbreaking Medical Cannabis epilepsy product, CannEpil™, into Australia and to its European clinical studies.
For MGC Pharma, this is a landmark step in providing Refractory Epilepsy patients in need with access to CannEpil™.